As a journal editor, are you tired of hearing the same excuses from authors who are facing allegations of problematic data? If so, you’re not alone. Recently, an editor of the journal Oncogene co-authored an editorial in the journal listing the types of excuses he often hears — and why none of them is valid. … Continue reading “My dog ate the data:” Eight excuses journal editors hear
The director of the Division of Investigative Oversight at the U.S. Office of Research Integrity is leaving the agency. Susan Garfinkel told Retraction Watch that her last day is November 10. She is taking a position as assistant vice president in the Office of Research Compliance at The Ohio State University (OSU). Garfinkel declined to … Continue reading Division director leaving U.S. research watchdog after nearly 15 years
The week at Retraction Watch featured the retraction of a paper from Yale on ketamine and depression, a retraction for Carlo Croce, and a discussion of when a citation may not be enough. Here’s what was happening elsewhere:
An EMBO journal has issued a correction for a well-cited 2012 review co-authored by a cancer researcher under investigation. Carlo Croce, the last author on the review, has been beleaguered by misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times), and his university has recently re-opened … Continue reading OSU researcher under investigation corrects paper cited 500 times
This weekend, Carlo Croce had some reprieve from the misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times) and that have prompted his university to re-open an investigation. On Sunday, he received a prestigious award from the American Association for Cancer Research, honoring his work. But the moment … Continue reading Journals retract paper, flag two others by cancer doc under investigation
This month hasn’t been all bad for Carlo Croce. Despite issuing two corrections and being the subject of a lengthy New York Times article about how he’s dodged misconduct accusations for years (prompting his institution to re-open an investigation), Croce is now the recipient of a prestigious award from the American Association for Cancer Research. In a recent … Continue reading Cancer org bestows award on scientist under investigation
Last July, Joseph Hilgard, a postdoctoral fellow at the Annenberg Public Policy Center at the University of Pennsylvania, saw an article in Gifted Child Quarterly that made him do a double take. Hilgard, who is studying the effects of violent media on aggressive behavior, said the results of the 2016 paper “caused me some alarm.” The … Continue reading Group whose findings support video game-violence link loses another paper
The chair of a biology department who has faced years of misconduct accusations has taken another hit—a lengthy correction due to text “overlap” between one of his PNAS papers and six other articles. According to the correction, a reader contacted the journal to notify the editors that text and sentences in multiple sections of the … Continue reading Another correction for prominent cancer researcher who’s dodged accusations for decades
Today isn’t a great day for Carlo Croce, chair of the department of cancer biology and genetics at The Ohio State University (OSU). The New York Times has a lengthy article detailing the misconduct accusations that have swirled around Croce for years. We’ve covered many, but The Gray Lady obtained documents that show there have been … Continue reading Cancer researcher has dodged accusations for decades (and has a new correction)
Researchers have retracted a biology paper that included an image mismatch — despite the fact that, as they claim, another image in the same paper confirms the original findings. The authors say they plan to resubmit the paper with the corrected figure panel. The second to last author — Carlo Croce, chair of the department of … Continue reading Journal retracts paper due to image mismatch; one co-author alleges fraud